Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd. (HKG:2566)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
7.10
-0.01 (-0.14%)
At close: Apr 17, 2026

HKG:2566 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
348.67537.6393.1871.5494.83
Short-Term Investments
365.7973.7532.9744.4432.97
Cash & Short-Term Investments
714.47611.38126.14115.98127.8
Cash Growth
16.86%384.68%8.76%-9.25%-
Accounts Receivable
601.77635.8522.11454.8393.98
Other Receivables
-2.974.145.3414.84
Receivables
601.77638.77526.24460.14408.82
Inventory
155.46149.12169.81171.9201.53
Other Current Assets
11.4710.717.5410.749.75
Total Current Assets
1,4831,410839.74758.76747.91
Property, Plant & Equipment
399.84354.23373.56385.8397.93
Other Intangible Assets
0.140.921.050.190.34
Long-Term Deferred Charges
208.36156.8990.365.630.45
Other Long-Term Assets
26.4813.053.246.58
Total Assets
2,1181,9231,3081,2141,183
Accounts Payable
48.3827.6443.2452.5466.85
Accrued Expenses
-68.8766.455.3250.03
Current Portion of Long-Term Debt
45.4981.01130.84141.53157.56
Current Portion of Leases
3.450.940.770.330.31
Current Income Taxes Payable
7.1414.370.44--
Current Unearned Revenue
20.6423.614.8116.8921.21
Other Current Liabilities
207.3125.2591.0289.31104.56
Total Current Liabilities
332.39341.69347.52355.93400.52
Long-Term Debt
57.0638.7734.5278.7345.81
Long-Term Leases
55.62-0.94-0.33
Long-Term Unearned Revenue
-6.067.277.562.5
Long-Term Deferred Tax Liabilities
15.4816.519.564.8413.29
Other Long-Term Liabilities
9.22-0.342.62
Total Liabilities
469.74405.01409.8447.4465.06
Common Stock
245.4245.420053.4553.45
Additional Paid-In Capital
-1,112681.43--
Retained Earnings
-150.7612.16673.73625.86
Comprehensive Income & Other
1,4039.64.339.0138.83
Shareholders' Equity
1,6481,518897.89766.18718.14
Total Liabilities & Equity
2,1181,9231,3081,2141,183
Total Debt
161.62120.72167.07220.58204
Net Cash (Debt)
552.85490.66-40.93-104.6-76.2
Net Cash Growth
12.67%----
Net Cash Per Share
2.252.40-0.20-0.52-0.38
Filing Date Shares Outstanding
245.4245.4200200200
Total Common Shares Outstanding
245.4245.4200200200
Working Capital
1,1511,068492.22402.82347.39
Book Value Per Share
6.726.194.493.833.59
Tangible Book Value
1,6481,517896.84765.99717.79
Tangible Book Value Per Share
6.726.184.483.833.59
Buildings
-276.41274.03271.85268.73
Machinery
-319.44307.57290.15271.78
Construction In Progress
-0.240.691.850.36
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.